Security key
00773U108
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)
CUSIP: 00773U108
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 56,103,335
- Total 13F value
- $646,305,236
- Share change
- +2,467,751
- Put/Call ratio
- 30%
- SEC-reported price per share
- $11.52
- Number of holders
- 114
- Value change
- +$34,182,922
- Number of buys
- 58
- Number of sells
- 48
- Shares outstanding
- 22,163,711
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2019
Institutions
114
Top holders
10
ADVM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2020
Previous quarter: Q3 2019
Adverum Biotechnologies, Inc. SEC filings
Adverum Biotechnologies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00773U108
Recent filing periods:
Ownership snapshot
Top reported holders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
28%
STATE STREET CORP
22%
BlackRock Finance, Inc.
20%
Avoro Capital Advisors LLC
19%
ORBIMED ADVISORS LLC
18%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
Company
|
28%
|
$34,231,000
6,281,003 shares
|
— | 30 Sep 2019 |
| STATE STREET CORP |
13F
Company
|
22%
|
$26,399,000
4,843,777 shares
|
— | 30 Sep 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
20%
|
$24,015,000
4,406,513 shares
|
— | 30 Sep 2019 |
| Avoro Capital Advisors LLC |
13F
Company
|
19%
|
$23,163,000
4,250,000 shares
|
— | 30 Sep 2019 |
| ORBIMED ADVISORS LLC |
13F
Company
|
18%
|
$21,871,000
4,012,969 shares
|
— | 30 Sep 2019 |
| VANGUARD GROUP INC |
13F
Company
|
12%
|
$14,945,000
2,742,221 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
56,103,335
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
98
Q4 2019 holders
114
Holder diff
16
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend